Farallon Capital Management’s Cogent Biosciences COGT Stock Holding History

Farallon Capital Management’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$658K	Hold	17,000	–	–	﹤0.01%	78
2026 Q1	$654K	Hold	17,000	–	–	﹤0.01%	106
2025 Q4	$604K	Hold	17,000	–	–	﹤0.01%	92
2025 Q3	$244K	Hold	17,000	–	–	﹤0.01%	113
2025 Q2	$122K	Hold	17,000	–	–	﹤0.01%	128
2025 Q1	$102K	Hold	17,000	–	–	﹤0.01%	136
2024 Q4	$133K	Hold	17,000	–	–	﹤0.01%	139
2024 Q3	$184K	Sell	17,000 -408,161	-96%	-$3.97M	﹤0.01%	145
2024 Q2	$3.58M	Sell	425,161 -36,839	-8%	-$279K	0.02%	96
2024 Q1	$3.1M	Buy	462,000 +445,000	+2,618%	+$2.75M	0.01%	108
2023 Q4	$100K	Hold	17,000	–	–	﹤0.01%	136
2023 Q3	$166K	Sell	17,000 -966,452	-98%	-$11.5M	﹤0.01%	133
2023 Q2	$11.6M	Hold	983,452	–	–	0.06%	88
2023 Q1	$10.6M	Buy	983,452 +898,313	+1,055%	+$11.5M	0.06%	97
2022 Q4	$984K	Sell	85,139 -160,000	-65%	-$1.98M	0.01%	173
2022 Q3	$3.66M	Sell	245,139 -754,861	-75%	-$10.3M	0.02%	191
2022 Q2	$9.02M	Buy	1,000,000 +150,000	+18%	+$1.02M	0.05%	142
2022 Q1	$6.37M	Buy	850,000 +250,000	+42%	+$1.74M	0.03%	173
2021 Q4	$5.15M	Hold	600,000	–	–	0.03%	180
2021 Q3	$5.05M	Hold	600,000	–	–	0.02%	182
2021 Q2	$4.87M	Hold	600,000	–	–	0.02%	185
2021 Q1	$5.27M	Hold	600,000	–	–	0.03%	181
2020 Q4	$6.74M	Buy	+600,000	New	+$6.59M	0.04%	114

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Farallon Capital Management's COGT Position: Q2 2026 in Review

Farallon Capital Management held its Cogent Biosciences (COGT) position steady in Q2 2026 at 17,000 shares worth $658K. The position accounts for ﹤0.01% of the portfolio, ranked #78.

Farallon Capital Management first reported a position in COGT in Q4 2020 and has held it in 23 quarters since. The position peaked at $11.6M in Q2 2023. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

Farallon Capital Management held 17,000 shares of Cogent Biosciences worth $658K as of Q2 2026.
Farallon Capital Management left its Cogent Biosciences share count unchanged in Q2 2026.
Cogent Biosciences made up ﹤0.01% of Farallon Capital Management's portfolio in Q2 2026, its #78 holding.
Farallon Capital Management first reported a position in Cogent Biosciences in Q4 2020 and has held it in 23 quarters since.
Farallon Capital Management's Cogent Biosciences position peaked at $11.6M in Q2 2023.
324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.